drugset / Trial / NCT03131154
SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.
Timeline
- Start
- 2017-04-26
- Primary completion
- 2019-04-19
- Completion
- 2019-04-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Reproxalap | Other / unclassified | 0.5 % | — |